The African Union Development Agency - New Partnership for Development (AUDA-NEPAD), through the African Programme for the Regulation and Coordination of Medicines (AMRH) initiative, has announced that it will launch the first phase of the drug evaluation pilot on the African continent through its Technical Committee on Drug Evaluation (EMP-TC). This work aims to test the role of the African Medicines Agency (AMA) to accelerate the review and registration of urgently needed medicines in Africa, and to lay a good foundation for future one-off evaluations on the continent through the AMA.
Interested companies can send an Expression of Interest (EOI) by December 22, 2023 to:
AUDAPilot@sahpra.org.za
alexj@nepad.org
dube.mzimba@sahpra.org.za
Please refer to the attachment to download the Letter of Intent. For more information, please visit the official website of AMRH: https://amrh.nepad.org/publication/call-industry-applications-pilot-of-continental-listing-of-medicinal-products
If you have any questions, please contact Shuwen Zhang, Xiaohui Zhang, 010-58036223/6325
Attachment: EOI
Attachment: EOI